Tirzepatide 50mg Research Pen

Tirzepatide 50mg Research Pen (4 x 12.5mg Research Dose)

Product Overview:

Tirzepatide is a synthetic peptide designed for advanced laboratory research. It functions as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors — two key pathways currently being explored in metabolic and endocrine research.

This Vitalis 10mg research pen delivers four precisely measured 2.5mg doses, offering researchers controlled and repeatable application throughout their studies. Tirzepatide has been widely studied for its potential influence on glucose metabolism, energy regulation, and insulin response, making it a cornerstone in modern peptide-based research.

Key Features:

• Concentration: 50mg total (4 x 12.5mg research doses)

• Form: Pre-measured research pen for precision dosing

• Purity: ≥ 99% (HPLC tested)

• Packaging: Sterile, sealed pen presentation for research use

• Storage: Keep in a cool, dry place. Once reconstituted, store refrigerated (2–8°C).

• Purpose: Laboratory research and analytical testing only

Research Interest Areas:

• Studied for its impact on insulin secretion and glucose control

• Investigated in relation to energy expenditure and metabolic regulation

• Research focus on GIP/GLP-1 receptor interactions and cell signaling pathways

• Potential interest in metabolic and peptide-based therapeutic studies

Why Choose Vitalis Research Peptides:
Vitalis products are developed with scientific precision and integrity, manufactured to the highest research standards, and verified through third-party laboratory analysis. Every compound is tested for purity and stability to ensure reliable, repeatable results for professional research use.

Important Notice:
All Vitalis products are intended strictly for laboratory research use only. They are not for human consumption, and not sold as drugs, food, or supplements.